Literature DB >> 7031097

Simplified procedure for the routine isolation of Clostridium difficile from faeces.

S P Borriello, P Honour.   

Abstract

The use of alcohol, at a final concentration of 50%, as a selective procedure for the isolation of Clostridium difficile was compared to a selective medium containing 250 microgram /ml of cycloserine and 10 microgram /ml of cefoxitin. Of 266 faecal samples 82 were shown to be positive by one or other method. Seventy-seven (94%) of these were detected by the selective agar (SA) and 72 (88%) by the alcohol procedure (AP). Ten samples (12%) were positive only by SA and five samples (6%) by AP only. The AP was further modified so that all manipulations prior to incubation were performed on the open bench. Of 18 positive samples, 18 (100%) were detected by SA and 16 (89%) by AP.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7031097      PMCID: PMC494377          DOI: 10.1136/jcp.34.10.1124

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  14 in total

1.  Transport and storage of faeces for bacteriological examination.

Authors:  J S Crowther
Journal:  J Appl Bacteriol       Date:  1971-06

2.  Experimental reproduction of neonatal diarrhea in young gnotobiotic hares simultaneously associated with Clostridium difficile and other Clostridium strains.

Authors:  J Dabard; F Dubos; L Martinet; R Ducluzeau
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

3.  Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia.

Authors:  J G Bartlett; T W Chang; M Gurwith; S L Gorbach; A B Onderdonk
Journal:  N Engl J Med       Date:  1978-03-09       Impact factor: 91.245

4.  Selective and differential medium for isolation of Clostridium difficile.

Authors:  W L George; V L Sutter; D Citron; S M Finegold
Journal:  J Clin Microbiol       Date:  1979-02       Impact factor: 5.948

5.  Cultures for Clostridium difficile in stools containing a cytotoxin neutralized by Clostridium sordellii antitoxin.

Authors:  S H Willey; J G Bartlett
Journal:  J Clin Microbiol       Date:  1979-12       Impact factor: 5.948

6.  Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis.

Authors:  J G Bartlett; N Moon; T W Chang; N Taylor; A B Onderdonk
Journal:  Gastroenterology       Date:  1978-11       Impact factor: 22.682

7.  Clostridium difficile associated diarrhoea: a role in inflammatory bowel disease?

Authors:  R P Bolton; R J Sherriff; A E Read
Journal:  Lancet       Date:  1980-02-23       Impact factor: 79.321

8.  Pseudomembranous colitis: Presence of clostridial toxin.

Authors:  H E Larson; A B Price
Journal:  Lancet       Date:  1977 Dec 24-31       Impact factor: 79.321

9.  Role of Clostridium difficile in a case of nonantibiotic-associated pseudomembranous colitis.

Authors:  S R Peikin; J Galdibini; J G Bartlett
Journal:  Gastroenterology       Date:  1980-11       Impact factor: 22.682

10.  Therapeutic implications of Clostridium difficile toxin during relapse of chronic inflammatory bowel disease.

Authors:  J T LaMont; Y M Trnka
Journal:  Lancet       Date:  1980-02-23       Impact factor: 79.321

View more
  31 in total

1.  The effects of storage conditions on viability of Clostridium difficile vegetative cells and spores and toxin activity in human faeces.

Authors:  J Freeman; M H Wilcox
Journal:  J Clin Pathol       Date:  2003-02       Impact factor: 3.411

2.  Evaluation of a commercial enzyme immunoassay kit for the detection of Clostridium difficile toxin A.

Authors:  S P Borriello; T Vale; J S Brazier; S Hyde; E Chippeck
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-04       Impact factor: 3.267

3.  Evaluation of a new molecular test, the BD Max Cdiff, for detection of toxigenic Clostridium difficile in fecal samples.

Authors:  Rémi Le Guern; Stéphanie Herwegh; Bruno Grandbastien; René Courcol; Frédéric Wallet
Journal:  J Clin Microbiol       Date:  2012-07-03       Impact factor: 5.948

4.  Use of a selective enrichment broth to recover Clostridium difficile from stool swabs stored under different conditions.

Authors:  Luis G Arroyo; Joyce Rousseau; Barbara M Willey; Don E Low; Henry Staempfli; Allison McGeer; J Scott Weese
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

5.  Evaluation of three rapid assays for detection of Clostridium difficile toxin A and toxin B in stool specimens.

Authors:  H Rüssmann; K Panthel; R-C Bader; C Schmitt; R Schaumann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-02       Impact factor: 3.267

6.  Treatment of relapsing Clostridium difficile diarrhoea by administration of a non-toxigenic strain.

Authors:  D Seal; S P Borriello; F Barclay; A Welch; M Piper; M Bonnycastle
Journal:  Eur J Clin Microbiol       Date:  1987-02       Impact factor: 3.267

7.  The effect of a single intravenous dose of cefotaxime on the faecal flora.

Authors:  D W Burdon; N S Ambrose; M R Keighley; D Youngs
Journal:  Infection       Date:  1985       Impact factor: 3.553

8.  Criteria for detection of Clostridium difficile toxin production by counterimmunoelectrophoresis.

Authors:  R P Rennie; J M Elliott; M A Nardini; J H Thornley
Journal:  J Clin Microbiol       Date:  1984-11       Impact factor: 5.948

9.  High frequency of antibiotic-associated diarrhea due to toxin A-negative, toxin B-positive Clostridium difficile in a hospital in Japan and risk factors for infection.

Authors:  M Komatsu; H Kato; M Aihara; K Shimakawa; M Iwasaki; Y Nagasaka; S Fukuda; S Matsuo; Y Arakawa; M Watanabe; Y Iwatani
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-08-21       Impact factor: 3.267

10.  Clostridium difficile: a new zoonotic agent?

Authors:  Alexander Indra; Heimo Lassnig; Nina Baliko; Peter Much; Anita Fiedler; Steliana Huhulescu; Franz Allerberger
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.